SFA Recent News

Sarcoma Foundation of America Announces 2020 Research Grant Awards

DAMASCUS, Md. – May 28, 2020 – The Sarcoma Foundation of America (SFA), an organization dedicated to increasing research and awareness for sarcoma, today announced that it has awarded three-quarters of a million dollars in research funds to deserving scientists as part of its 2020 SFA Research Grant program.  Fifteen research grants, each worth $50,000, have been awarded to researchers who have made it their mission to study sarcoma, a cancer that arises in the body’s soft tissue and bone. All proposals are peer reviewed by members of the SFA Medical Advisory Board who award the grants to the best,…  Read More »

Sarcoma and Coronavirus: What Now?

Now that many states and localities are starting to lift shelter-in-place restrictions and move into phases of reopening, what do sarcoma patients need to know? As a follow-up to our April session, the Sarcoma Foundation of America is reuniting the panel of sarcoma experts to share their thoughts on how COVID-19 may continue to impact care and what sarcoma patients need to know as we begin the phases of reopening. Our multidisciplinary panel will answer your questions and address concerns on issues of care, the impact on research and clinical trials, and next steps as we move forward.     Saturday,…  Read More »

COVID-19, Collaboration and Sarcoma

By Brandi Felser, Executive Director COVID-19, Collaboration & Sarcoma Treating cancer like a pandemic: Collaboration is necessary to cure sarcoma COVID-19 has hit us like a wrecking ball. There is no part of society that has gone untouched. Despite the damage this pandemic has done, there has been some positive. The “system” of science has been upended and the science community has united, focused on one goal. All of our resources are being pooled to fight this virus. Data and information are being shared in new ways, shared faster and are freely available. #MedTwitter and other science threads offer information…  Read More »

Race to Cure Sarcoma Needs You Now More Than Ever

  The Race to Cure Sarcoma needs you now more than ever!   The current COVID-19 situation has caused events all over the country to be rescheduled or canceled. At the Sarcoma Foundation of America (SFA), the safety of sarcoma patients and RTCS participants are our top priority.   SFA is closely following federal government and individual state reopening plans and SFA is taking these plans into consideration as we make decisions to reschedule events or change to virtual events.   We know we must continue our goal of supporting research that leads to life saving treatments for sarcoma patients…  Read More »

Help Cure Sarcoma on #GivingTuesdayNow

The heart of the Sarcoma Foundation of America is research and donors like you have made SFA the leading research and sarcoma patient advocacy organization in the country. Join SFA for the GivingTuesdayNow Global Campaign Around the end of November each year, people all over the world come together and donate for GivingTuesday.  We are always awestruck by the sense of community created when millions of people collectively support charitable organizations on a single day. GivingTuesdayNow is a new global effort being held on May 5 to promote charitable organizations and their need for support during these uncertain times. SFA is…  Read More »

Advocate Profile: Brittany Symonds

  “I refuse to let cancer win. Cancer will not determine how I live.” -Brittany Symonds   A sarcoma diagnosis can have a life changing impact on the lives of those in our communities, but one of our advocates and Race to Cure Sarcoma Tampa participants is showing us that we do not have to let this diagnosis take away from us what we love in life.    Brittany Symonds was diagnosed in summer of 2015 with leiomyosarcoma in her leg after she was injured when playing softball. This led to more than 11 surgeries, radiation, multiple scans, and having to face the…  Read More »

SFA Joins Other Cancer Organizations on Pandemic Response Letters

The Sarcoma Foundation of America joined more than 50 other cancer organizations on letters to Congress and Department of Health and Human Services Secretary Alex Azar calling on legislators and the Administration to  ensure that cancer patients have access to health coverage and treatment during the COVID-19 pandemic.  The letters address pressing needs including oral chemotherapy parity, access to 90-day supplies of medications, and reliable access to telehealth services.   Letter to Congress Letter of Health and Human Services Secretary Alex Azar    

Sarcoma & Coronavirus: Your Questions Answered

  In response to the COVID-19 outbreak, the Sarcoma Foundation of America (SFA) held a live, online session with a panel of sarcoma experts to discuss the impact the coronavirus pandemic is having on sarcoma patients and survivors.  Panelists Brian Van Tine, MD, PhD, Washington University in St. Louis, Kurt Weiss, MD, University of Pittsburgh School of Medicine, and Breelyn Wilky, MD, University of Colorado Cancer Center, answered questions submitted by the sarcoma community.  The panelists shared input on issues related to how on patients can communicate with their physicians on the risks and benefits of current care and treatment…  Read More »

Message to the Sarcoma Community

Like most of you, the Sarcoma Foundation of America (SFA) has been closely following news regarding the novel coronavirus, COVID-19.  While many questions remain regarding the impact that it will have in the United States, SFA is following recommended protocol to help stop the spread by closing our office and teleworking. SFA will continue our efforts to advocate for sarcoma patients and their families and is still available to serve as a resource to the sarcoma community.  You can reach the SFA by phone at 301-253-8687 or by email at info@curesarcoma.org. We are evaluating upcoming events and will be announcing…  Read More »

Twenty Years of the SFA

By Brandi Felser, Executive Director Twenty years later, SFA continues to be a voice and leader for the sarcoma community. Twenty years ago, before SFA, not much attention was paid to sarcoma. There were few treatment options, and no organization or institution focused on developing new therapies or expediting new treatments for patients. Sarcoma was a forgotten cancer. Fast forward 20 years. Sarcoma awareness has substantially increased, more, though not nearly enough, therapies are available, and innovative and novel agents such as immune-oncology are beginning to be applied to sarcoma. And SFA has shown that we have the ability to…  Read More »